glp 1 glucagon dual agonist Discovery of Biased Dual-Agonists of Glucagon-Like Peptide and Receptors through Mutation of a Conserved Aspartate Structural analysis of the dual

Discover proper techniques for current injectable GLP-1 medications and what to know about future transdermal delivery systems.

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

Low-income Californians who use Wegovy and similar medications for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead

This once-daily capsule offers more robust support than standard multivitamins

The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity

Globally, 90% of diabetes patients have TIIDM